Evidence map›Paper›PMID 40178685›Full record

SynthesisNeurogenetics2025

Genetic variants associated with idiopathic Parkinson's disease in Latin America: A systematic review.

Felipe Duarte-Zambrano, David Felipe Alfonso-Cedeño, Jorge A Barrero, Luis Alejandro Rodríguez-Vanegas, Valentina Moreno-Cárdenas, Anamaría Olarte-Díaz, Gonzalo Arboleda, Humberto Arboleda

Abstract readSystematic Review
In one paragraph

Synthesis in Neurogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Felipe Duarte-ZambranoSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia. jduartez@unal.edu.co.ORCID http://orcid.org/0000-0003-2665-1568
David Felipe Alfonso-CedeñoSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0003-2756-9638
Jorge A BarreroSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0003-2958-5551
Luis Alejandro Rodríguez-VanegasSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0009-0002-4459-3963
Valentina Moreno-CárdenasSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0009-0001-4818-0632
Anamaría Olarte-DíazSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-9488-426X
Gonzalo ArboledaGrupo de Investigación en Neurociencias y Muerte Celular, Facultad de Medicina E Instituto de Genética, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0003-1781-939X
Humberto ArboledaSemillero de Investigación en Neurociencias, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, Colombia.ORCID http://orcid.org/0000-0002-4962-0310

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Idiopathic Parkinson's disease (PD) constitutes a complex trait influenced by genetic, environmental, and lifestyle factors, with an estimated heritability of nearly 30%. However, a large proportion of the heritable variation linked to PD remains uncertain, partly due to ancestral bias. Expanding research into Hispanic populations can contribute to address this gap. To review the evidence of genetic variants associated with idiopathic PD in Latin America. A PRISMA-compliant systematic review was conducted in MEDLINE, EMBASE and LILACS, compiling studies published up to February 7, 2025. Nineteen case-control studies were included. Two hypothesis-free studies identified rs525496 near H2BW1 as a protective factor and rs356182 in SNCA as a risk factor through XWAS and GWAS, respectively. Seventeen hypothesis-driven studies examined over three hundred variants, identifying nineteen genetic markers; risk factors included one INDEL in NR4A2, CNV burdens in PRKN, SNCA, and PLA2G6, along with fourteen variants in six loci including GBA, APOEε4, MTHFR, LRRK2, and SNCA. Three SNPs in the PICALM, ALDH1A1, and APOE-ε3 loci were identified as protective factors. Additionally, six SNCA variant haplotypes appear to increase PD risk, while two NR4A2 INDELs haplotypes showed mixed effects. This review summarized genetic loci associated with idiopathic PD in Latin American populations evidencing an overlap with European findings as well as novel loci, although awaiting replication and validation. These observations contribute to the understanding of genetic configuration of the disease and highlight the need for further genomic research in underrepresented groups that include local ancestry analysis within admixed cohorts to guide development of personalized treatments and population-specific interventions.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationParkinson Diseasealpha-SynucleinGenome-Wide Association StudyHumansLatin AmericaPolymorphism, Single NucleotideRisk Factorsalpha-SynucleinSNCA protein, humanCandidate geneComplex diseaseGenetic architectureGenetic association studiesGWASLatin AmericaParkinson’s diseaseSystematic reviewXWAS

Identifiers

PMID40178685
PMCPMC11968493

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.